Envoy Medical, Inc. - Class A Common Stock (COCH)

Stay up-to-date with the latest market trends one hour before the close of the markets on Monday. Explore the top gainers and losers during today's session in our detailed report.

Looking for insights into the US markets in the middle of the day on Monday? Delve into the top gainers and losers of today's session and gain valuable market intelligence.

Investors and traders are closely monitoring the gap up and gap down stocks in today's session on Monday. Let's explore the market movements and identify the stocks with significant gaps.

The US market session of Monday has yet to be opened, let's have a look at the top gainers and losers in the pre-market session today.

The US market session of Friday has yet to be opened, let's have a look at the top gainers and losers in the pre-market session today.

Envoy Medical settled $32 million in loans for $100K and announced Glen Taylor's retirement after 20 years, citing confidence in its clinical trial progress.

COCH stock results show that Envoy Medical missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024.

COCH stock results show that Envoy Medical missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024.

Shares of Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) fell sharply during Monday’s session after the company revealed new data from the Phase 1/2 study of GTX-102 for Angelman syndrome, a genetic disorder causing developmental disabilities and nerve-related symptoms.